NUTRA PHARMA CORP (CIK: 0001119643) EDGAR, Information, Filings... CompaniesBIO.Com

NUTRA PHARMA CORP

Mailing address
12538 W. ATLANTIC BLVD., CORAL SPRINGS, California, 33071
Phone
(954) 509-0911
State location
Florida
State of incorporation
California
Fiscal year end
December 31
SIC
2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Filings
N/A

NUTRA PHARMA CORP (CIK: 0001119643) is an American company incorporated in the state of Florida. Head office is located at 12538 W. ATLANTIC BLVD., CORAL SPRINGS, Florida, 33071. Work in the industry 2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS. NUTRA PHARMA CORP is a public company and trade via Over-The-Counter (OTC).

Old names:

CYBER VITAMIN COM from 2000-03-Oct to 2002-28-Feb

Owner	Filings	Transaction Date	Type of Owner
ORAN DAN	0001705481	Jun-17-2016	director
SARTORI BRUNO	0001108410	Feb-10-2012	other: Former CFO
Rumph Harold Henry	0001476235	Feb-10-2012	director, officer: President - ReceptoPharm
ISSERMAN DAVID MICHAEL	0001483799	Feb-11-2010	officer: Chief Marketing Officer
POTTRUCK GARRY	0001480951	Jul-29-2009	director
REID PAUL F	0001481668	Apr-14-2008	director
DOHERTY MICHAEL	0001251265	Jun-01-2005	director, officer: Executive Chairman
Khandaker Tanvir A	0001322964	Jan-26-2005	director
Lonky Stewart Alan	0001323546	Jan-26-2005	director
CHERELSTEIN STANLEY JACK	0001322956	Nov-05-2004	director
FLAX MICHAEL	0001168729	Nov-30-2003	director, officer: Chief Financial Officer
MCCLELLAND DAVID C SR	0001285083	Nov-17-2003	director
FELDER MITCHELL S	0001285072	Oct-30-2003	director
DEITSCH RIK J	0001266490	Jun-09-2003	officer: Chief Executive Officer
KHALSA SORAM SINGH MD	0001168730	Dec-31-2002	director
ENGELBRECHT ZIRK	0001169361	Dec-31-2002	director, officer: Chief Financial Officer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by NUTRA PHARMA CORP

Filings	Format	Description	Filed/Effective	File/Film Number
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-25-028946 (34 Act) Size: KB	Dec-23-2025	000-32141 251597750
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-25-028202 (34 Act) Size: KB	Dec-17-2025	000-32141 251580109
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-25-024800 (34 Act) Size: KB	Nov-24-2025	000-32141 251511765
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-25-019875 (34 Act) Size: KB	Oct-28-2025	000-32141 251424738
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-25-019037 (34 Act) Size: KB	Oct-23-2025	000-32141 251412423
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-25-018328 (34 Act) Size: KB	Oct-16-2025	000-32141 251398076
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001641172-25-026446 (34 Act) Size: KB	Sep-03-2025	000-32141 251291162
8-K	Document	Current report filing Acc-no: 0001641172-25-026384 (34 Act) Size: KB	Sep-03-2025	000-32141 251289409
8-K	Document	Current report filing Acc-no: 0001493152-24-010998 (34 Act) Size: KB	Mar-22-2024	000-32141 24775829
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-22-033171 (34 Act) Size: KB	Nov-21-2022	000-32141 221406817
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001493152-22-032495 (34 Act) Size: KB	Nov-15-2022	000-32141 221391185
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-22-023751 (34 Act) Size: KB	Aug-22-2022	000-32141 221184372
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001493152-22-022953 (34 Act) Size: KB	Aug-15-2022	000-32141 221166542
8-K	Document	Current report filing Acc-no: 0001493152-22-021351 (34 Act) Size: KB	Aug-04-2022	000-32141 221137342
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-22-014637 (34 Act) Size: KB	May-20-2022	000-32141 22948445
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001493152-22-013761 (34 Act) Size: KB	May-16-2022	000-32141 22928782
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-22-010035 (34 Act) Size: KB	Apr-15-2022	000-32141 22829456
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001493152-22-008863 (34 Act) Size: KB	Apr-01-2022	000-32141 22799113
DEF 14C	Document	Definitive information statements Acc-no: 0001493152-22-007568 (34 Act) Size: KB	Mar-24-2022	000-32141 22764112
5	Document	Annual statement of changes in beneficial ownership of securities Acc-no: 0001493152-22-001313 ( Act) Size: 0 KB	Jan-14-2022

Recent 20 filings. View all NUTRA PHARMA CORP filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

NUTRA PHARMA CORP overview
NUTRA PHARMA CORP job
NUTRA PHARMA CORP stock
NUTRA PHARMA CORP ownership
NUTRA PHARMA CORP CEO
NUTRA PHARMA CORP documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.